|
|
Tyler J. Curiel, David T. Curiel
J Clin Invest. 2002;
109(3):311
doi:10.1172/JCI15042
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(6)
| Title and authors |
Publication |
Year |
In situ regulation of DC subsets and T cells mediates tumor regression in mice.
Omar A Ali, Dwaine Emerich, Glenn Dranoff, David J Mooney
|
Science Translational Medicine
|
2009 |
Immunology and immunotherapy approaches for prostate cancer
E Elkord
|
Prostate Cancer Prostatic Dis
|
2007 |
Tregs and rethinking cancer immunotherapy
Tyler J. Curiel
|
J. Clin. Invest.
|
2007 |
Regulatory T Cells in Ovarian Cancer: Biology and Therapeutic Potential
Brian Barnett, Ilona Kryczek, Pui Cheng, Weiping Zou, Tyler J. Curiel
|
American Journal of Reproductive Immunology
|
2005 |
Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
S Rutkowski, S De Vleeschouwer, E Kaempgen, J E A Wolff, J Kühl, P Demaerel, M Warmuth-Metz, P Flamen, F Van Calenbergh, C Plets, N Sörensen, A Opitz, S W Van Gool
|
Br J Cancer
|
2004 |
Strategies for Prostate Cancer Gene Therapy
Yehoshua Gdor, Terry L Timme, Dov Kadmon, Brian J Miles, Timothy C Thompson
|
American Journal of Cancer
|
2004 |
|
